The central government has approved the use of Bharat Biotech’s nasal Covid vaccine iNCOVACC to be included in the country’s vaccination programme as a booster dose for those above 18 years of age. The Union Health Ministry said that those who have taken Covishield and Covaxin can take the nasal vaccine as a heterologous booster dose.
About the Author
